申请人:Santen Pharmaceutical Co. Ltd.
公开号:US03971828A1
公开(公告)日:1976-07-27
Compounds useful for prophylaxis and therapy in treating a metabolic disorder, such as nosotoxicosis due to a heavy metal radiation disorder, diabetes or hepatitis. ##EQU1## and intermediates therefor are disclosed.
本发明涉及用于预防和治疗代谢紊乱的化合物,例如由重金属辐射引起的毒性病,糖尿病或肝炎。揭示了##EQU1##及其中间体。